Wednesday, January 12, 2022 9:18:44 AM
Recent BJDX News
- Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering • GlobeNewswire Inc. • 01/02/2024 10:58:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:21:42 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 12/29/2023 10:06:56 PM
- Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering • GlobeNewswire Inc. • 12/28/2023 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/28/2023 05:15:12 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/27/2023 07:29:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 02:14:38 PM
- Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) • GlobeNewswire Inc. • 12/27/2023 02:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:20:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:17:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:16:33 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2023 10:27:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:05:30 PM
- Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 01:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 08:23:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:43:21 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/28/2023 11:00:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 12:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:25:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:01:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 12:10:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM